<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35951203</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7209</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Angiogenesis</Title><ISOAbbreviation>Angiogenesis</ISOAbbreviation></Journal><ArticleTitle>Persistent capillary rarefication in long COVID syndrome.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>61</EndPage><MedlinePgn>53-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10456-022-09850-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recent studies have highlighted Coronavirus disease 2019 (COVID-19) as a multisystemic vascular disease. Up to 60% of the patients suffer from long-term sequelae and persistent symptoms even 6&#xa0;months after the initial infection.</AbstractText><AbstractText Label="METHODS">This prospective, observational study included 58 participants, 27 of whom were long COVID patients with persistent symptoms&#x2009;&gt;&#x2009;12&#xa0;weeks after recovery from PCR-confirmed SARS-CoV-2 infection. Fifteen healthy volunteers and a historical cohort of critically ill COVID-19 patients (n&#x2009;=&#x2009;16) served as controls. All participants underwent sublingual videomicroscopy using sidestream dark field imaging. A newly developed version of Glycocheck&#x2122; software was used to quantify vascular density, perfused boundary region (PBR-an inverse variable of endothelial glycocalyx dimensions), red blood cell velocity (VRBC) and the microvascular health score (MVHS&#x2122;) in sublingual microvessels with diameters 4-25&#xa0;&#xb5;m.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Although dimensions of the glycocalyx were comparable to those of healthy controls, a &#xb5;m-precise analysis showed a significant decrease of vascular density, that exclusively affected very small capillaries (D5: -&#xa0;45.16%; D6: -&#xa0;35.60%; D7: -&#xa0;22.79%). Plotting VRBC of capillaries and feed vessels showed that the number of capillaries perfused in long COVID patients was comparable to that of critically ill COVID-19 patients and did not respond adequately to local variations of tissue metabolic demand. MVHS was markedly reduced in the long COVID cohort (healthy 3.87 vs. long COVID 2.72 points; p&#x2009;=&#x2009;0.002).</AbstractText><AbstractText Label="CONCLUSIONS">Our current data strongly suggest that COVID-19 leaves a persistent capillary rarefication even 18&#xa0;months after infection. Whether, to what extent, and when the observed damage might be reversible remains unclear.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osiaevi</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital M&#xfc;nster, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulze</LastName><ForeName>Arik</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital M&#xfc;nster, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evers</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital M&#xfc;nster, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmening</LastName><ForeName>Kimon</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital M&#xfc;nster, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vink</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;mpers</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine D, Division of General Internal and Emergency Medicine, Nephrology, and Rheumatology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mohr</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine A, Hematology, Oncology and Pulmonary Medicine, University Hospital M&#xfc;nster, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rovas</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine D, Division of General Internal and Emergency Medicine, Nephrology, and Rheumatology, University Hospital M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany. alexandros.rovas@ukmuenster.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Angiogenesis</MedlineTA><NlmUniqueID>9814575</NlmUniqueID><ISSNLinking>0969-6970</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002196" MajorTopicYN="Y">Capillaries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019276" MajorTopicYN="N">Glycocalyx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Endothelial glycocalyx</Keyword><Keyword MajorTopicYN="N">Endotheliopathy</Keyword><Keyword MajorTopicYN="N">Long COVID microcirculation</Keyword><Keyword MajorTopicYN="N">Microvascular health score</Keyword><Keyword MajorTopicYN="N">Sublingual microscopy</Keyword></KeywordList><CoiStatement>IO, AS, GE, KH, PK, MM and AR declare that they have no competing interests. HV is Chief Science Officer of GlycoCheck&#x2122; BV, The Netherlands. GlycoCheck&#x2122; and MVHS&#x2122; are trademarks registered by Microvascular Health Solutions LLC (Alpine, UT, United States).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35951203</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pii">10.1007/s10456-022-09850-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, Jonigk D, Chocron R, Pier GB, Gendron N, et al. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021;24(4):755&#x2013;788. doi: 10.1007/s10456-021-09805-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-021-09805-6</ArticleId><ArticleId IdType="pmc">PMC8238037</ArticleId><ArticleId IdType="pubmed">34184164</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353. doi: 10.1186/s13054-020-03062-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03062-7</ArticleId><ArticleId IdType="pmc">PMC7296907</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, Kuhn J, Braune S, Gobel U, Tholking G, et al. Microvascular dysfunction in COVID-19: the MYSTIC study. Angiogenesis. 2021;24(1):145&#x2013;157. doi: 10.1007/s10456-020-09753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-020-09753-7</ArticleId><ArticleId IdType="pmc">PMC7556767</ArticleId><ArticleId IdType="pubmed">33058027</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Saevik M, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-: a clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Sackarnd J, Rossaint J, Kampmeier S, Pavenstadt H, Vink H, Kumpers P. Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study. Crit Care. 2021;25(1):112. doi: 10.1186/s13054-021-03520-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03520-w</ArticleId><ArticleId IdType="pmc">PMC7980588</ArticleId><ArticleId IdType="pubmed">33741036</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Silva M, Dao M, Han J, Lim CT, Suresh S. Shape and biomechanical characteristics of human red blood cells in health and disease. MRS Bull. 2010;35(5):382&#x2013;388. doi: 10.1557/mrs2010.571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1557/mrs2010.571</ArticleId><ArticleId IdType="pmc">PMC2998922</ArticleId><ArticleId IdType="pubmed">21151848</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, Vicente A, Park M, Manalan K, Wallner I, Marsden P, Dave S, Branley H, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9(1):107&#x2013;116. doi: 10.1016/S2213-2600(20)30407-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Evers G, Schulze AB, Osiaevi I, Harmening K, Vollenberg R, Wiewrodt R, Pistulli R, Boentert M, Tepasse PR, Sindermann JR, et al. Sustained impairment in cardiopulmonary exercise capacity testing in patients after COVID-19: a single center experience. Can Respir J. 2022;2022:2466789. doi: 10.1155/2022/2466789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2466789</ArticleId><ArticleId IdType="pmc">PMC8886771</ArticleId><ArticleId IdType="pubmed">35242250</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos S, Chatzantonis G, Bietenbeck M, Evers G, Schulze AB, Mohr M, Fonfara H, Meier C, Yilmaz A. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep. 2021;11(1):15667. doi: 10.1038/s41598-021-95277-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95277-z</ArticleId><ArticleId IdType="pmc">PMC8329060</ArticleId><ArticleId IdType="pubmed">34341436</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, Bahloul A, Kallel N, Moussa N, Touil I, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8:745758. doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibnhadjamor H, Jdidi J, Torjmen S, Kraiem S, Bahloul A, Makni A, Kallel N, Moussa N, Boudaya M, et al. Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: insights from TUN-EndCOV study. Front Cardiovasc Med. 2022;9:866113. doi: 10.3389/fcvm.2022.866113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.866113</ArticleId><ArticleId IdType="pmc">PMC9133483</ArticleId><ArticleId IdType="pubmed">35647070</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollenberg R, Tepasse PR, Ochs K, Floer M, Strauss M, Rennebaum F, Kabar I, Rovas A, Nowacki T. Indications of persistent glycocalyx damage in convalescent COVID-19 patients: a prospective multicenter study and hypothesis. Viruses. 2021 doi: 10.3390/v13112324.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112324</ArticleId><ArticleId IdType="pmc">PMC8619155</ArticleId><ArticleId IdType="pubmed">34835130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambadiari V, Mitrakou A, Kountouri A, Thymis J, Katogiannis K, Korakas E, Varlamos C, Andreadou I, Tsoumani M, Triantafyllidi H, et al. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection. Eur J Heart Fail. 2021;23(11):1916&#x2013;1926. doi: 10.1002/ejhf.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2326</ArticleId><ArticleId IdType="pmc">PMC8426810</ArticleId><ArticleId IdType="pubmed">34415085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidis I, Lambadiari V, Mitrakou A, Kountouri A, Katogiannis K, Thymis J, Korakas E, Pavlidis G, Kazakou P, Panagopoulos G, et al. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection. Eur J Heart Fail. 2022 doi: 10.1002/ejhf.2451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2451</ArticleId><ArticleId IdType="pmc">PMC9087421</ArticleId><ArticleId IdType="pubmed">35138689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukasz A, Hillgruber C, Oberleithner H, Kusche-Vihrog K, Pavenstadt H, Rovas A, Hesse B, Goerge T, Kumpers P. Endothelial glycocalyx breakdown is mediated by angiopoietin-2. Cardiovasc Res. 2017;113(6):671&#x2013;680. doi: 10.1093/cvr/cvx023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvx023</ArticleId><ArticleId IdType="pubmed">28453727</ArticleId></ArticleIdList></Reference><Reference><Citation>Buijsers B, Yanginlar C, de Nooijer A, Grondman I, Maciej-Hulme ML, Jonkman I, Janssen NAF, Rother N, de Graaf M, Pickkers P, et al. Increased plasma heparanase activity in COVID-19 patients. Front Immunol. 2020;11:575047. doi: 10.3389/fimmu.2020.575047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.575047</ArticleId><ArticleId IdType="pmc">PMC7573491</ArticleId><ArticleId IdType="pubmed">33123154</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20(1):138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovas A, Seidel LM, Vink H, Pohlkotter T, Pavenstadt H, Ertmer C, Hessler M, Kumpers P. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis. Crit Care. 2019;23(1):260. doi: 10.1186/s13054-019-2542-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2542-2</ArticleId><ArticleId IdType="pmc">PMC6657098</ArticleId><ArticleId IdType="pubmed">31340868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E, Badimon L, Bugiardini R, Claeys MJ, De Luca G, de Wit C, Derumeaux G, Dorobantu M, Duncker DJ, Eringa EC, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology &amp; Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) Cardiovasc Res. 2021;117(14):2705&#x2013;2729. doi: 10.1093/cvr/cvab298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab298</ArticleId><ArticleId IdType="pmc">PMC8500019</ArticleId><ArticleId IdType="pubmed">34528075</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>